Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Single-Blinded, Randomized Study of Nebulized RNS60 in Combination With Budesonide in Adult Subjects With Mild to Moderate Asthma

NCT01511302 is registered in ClinicalTrials.gov with Revalesio Corporation as lead sponsor.

NCT NCT01511302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01511302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Single-Blinded, Randomized Study of Nebulized RNS60 in Combination With Budesonide in Adult Subjects With Mild to Moderate Asthma
Lead sponsor
Revalesio Corporation
Phase
Phase 1
Overall status
Completed
Start date
June 30, 2012
Completion date
May 31, 2013
Enrollment
65 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

asthma